#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arginase deficiency High-grade B-cell lymphoma Chondrosarcoma metastatic Malignant oligodendroglioma Vitamin B12 deficiency Small cell lung cancer HER2 gene amplification Cholangiocarcinoma Hyperphagia Parkinson's disease Liver transplant rejection Inflammatory myofibroblastic tumour Paraganglion neoplasm Gestational trophoblastic tumour Oesophageal adenocarcinoma stage III More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Life with Disease Lymphangioma – Treatment Sjogren’s syndrome Haemophagocytic lymphohistiocytosis Glomerulonephritis membranoproliferative – Life with Disease Phenylketonuria Cystic fibrosis – Trials in Disease Loeys-Dietz syndrome – Life with Disease Synovial sarcoma – Life with Disease Congenital nephrogenic diabetes insipidus More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Satoreotide Tetraxetan Elivaldogene Autotemcel Sym025 Teriparatide Desonide Neostigmine Methylsulfate S095035 Tulisokibart Betaxolol Pramlintide Acetate Vanglusagene Ensiparvovec POLYMYXIN B SULFATE Sacituzumab Tirumotecan Levetiracetam Lorazepam Elexacaftor Wt1/Il15/Il15Ra Mrna Dc Bi 764532 Aluminium Cefixime Trihydrate More therapies…

    Learn about Your Condition

    Depression Medulloblastoma Generalised anxiety disorder Metastases to lymph nodes Hypoglycaemia Cardiac failure congestive Precocious puberty Endolymphatic hydrops Dedifferentiated liposarcoma Major depression Naevus flammeus Sarcoma Testicular germ cell cancer Blood iron increased Vaginal haemorrhage More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Peripheral arterial occlusive disease

  • Study on Low-Dose Colchicine for Patients with Peripheral Artery Disease to Reduce Cardiovascular Risks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Intermittent claudication
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Colchicine
    Belgium Germany Italy The Netherlands

  • Study on Preventing Kidney Problems in Peripheral Arterial Disease Patients Using Carbon Dioxide and Iopamidol, Iomeprol, and Iopromide During Vascular Procedures

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Iomeprol
    • Iopamidol
    • Iopromide
    Austria Germany

  • Study on Bone Marrow Cells and Saline for Treating Severe Limb Ischemia in Patients at High Risk of Amputation

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Saline
    Spain

  • Study on the Effectiveness of Autologous Bone Marrow-Derived Mononuclear Cells and Angioplasty in Diabetic Patients with Chronic Limb-Threatening Ischemia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • AUTOLOGOUS BONE MARROW-DERIVED MONONUCLEAR CELLS
    Czechia

  • Study on Genotype-Guided Treatment with Carbasalate Calcium, Telmisartan, and Rivaroxaban for Patients with Peripheral Arterial Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Carbasalate Calcium
    • Lactose Monohydrate
    • Telmisartan
    The Netherlands

  • Study of sildenafil to improve walking distance in patients with peripheral arterial disease and intermittent claudication

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Sildenafil Citrate
    France
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!